Meron Shiferaw graduated from California State University, San Bernardino with a B.S. in Chemistry. She is an Analytical Chemist with expertise in drug metabolite analysis for personalized delivery of chemotherapy agents. For the past 14 years, Meron has contributed to research, development, and quality control in both industry and now in academics, at City of Hope. Her expertise is in quality control (GMP and GLP environment), method development, and execution of validation protocols according to USP29/NF24 standards, with experience working with High-Performance Liquid Chromatography/Mass Spectroscopy (LC/MS/MS), GCMS, ICPMS, GC, FTIR, AA, and UV Spectra.
While in industry Meron was involved in improving procedures by assisting in making adjustments to the formula as needed to be within spec by evaluating viscosity, specific gravity, water analysis, pH, and melting point. She studied the analytical aspects of QC functional group standards by testing and periodic quarantining, sampling of raw materials, and finished products using qualitative and quantitative analysis techniques.
Meron started working at City of Hope in 2017 as a Senior Research Associate and has worked on projects focusing on pharmacokinetics and metabolomics studies of chemotherapy agents for personalized medicine studies. Her studies focused on identifying and quantitating metabolites of both Busulfan and Cyclophosphamide to improve efficacy, reduce relapse, and limit toxicity. Her assays are currently being used both as research tools, and also to improve delivery of care in the transplantation and post-transplantation setting. Meron is working under Dr. Sistrunk in the Health Equities department focusing on the environmental impacts on drinking water and how underrepresented communities are affected genetically through chronic exposures.
Fun Fact: Meron likes making her skin care products.